Search results for "Placement."

showing 10 items of 1123 documents

Morbidity in 565 Type 2 Diabetic Patients According to Stage of Nephropathy

1998

Between 1988 and 1992, 565 type 2 diabetic patients were examined for nephropathy and diabetes-associated diseases during hospital treatment. Stages of nephropathy were defined as no clinical sign of nephropathy (N = 280), microalbuminuria (N = 38), overt proteinuria (N = 105), impaired renal function (N = 55), and chronic dialysis therapy (N = 87). In dialyzed patients, HbA1c averaged 6.8%, and, in the other groups, HbA1c was between 7.6% and 8.3% (normal range, 3.8%-6.1%). Cataract was not associated with the severity of nephropathy. Stroke was most common in the stage of renal insufficiency (34%). The following complications, as found in medical history or as current event, showed a sign…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMyocardial InfarctionBlood PressureGastroenterologyNephropathyCohort StudiesDiabetic nephropathyEndocrinologyRisk FactorsInternal medicineDiabetes mellitusInternal MedicinemedicineAlbuminuriaHumansCarotid StenosisDiabetic NephropathiesRenal replacement therapyAgedDiabetic RetinopathyProteinuriabusiness.industryMiddle Agedmedicine.diseaseSurgeryRenal Replacement TherapyCerebrovascular DisordersProteinuriaDiabetes Mellitus Type 2HypertensionAlbuminuriaFemaleHypertrophy Left VentricularMicroalbuminuriaMorbiditymedicine.symptombusinessKidney diseaseJournal of Diabetes and its Complications
researchProduct

Evaluation of total alloplastic temporo-mandibular joint replacement with two different types of prostheses : a three-year prospective study

2015

Background Temporo-Mandibular Joint (TMJ) replacement has been used clinically for years. The objective of this study was to evaluate outcomes achieved in patients with two different categories of TMJ prostheses. Material and Methods All patients who had a TMJ replacement (TMJR) implanted during the study period from 2006 through 2012 were included in this 3-year prospective study. All procedures were performed using the Biomet Microfixation TMJ Replacement System, and all involved replacing both the skull base component (glenoid fossa) and the mandibular condyle. Results Fifty-seven patients (38 females and 19 males), involving 75 TMJs with severe disease requiring reconstruction (39 unila…

AdultMalemedicine.medical_specialtyFossamedicine.medical_treatmentJoint ProsthesisDentistryTemporo mandibular jointCondyle03 medical and health sciences0302 clinical medicinestomatognathic systemMedicineHumansIn patientProspective StudiesArthroplasty ReplacementProspective cohort studyGeneral DentistryAgedbiologyTemporomandibular Jointbusiness.industryResearch030206 dentistryMiddle AgedTemporomandibular Joint Disordersbiology.organism_classification:CIENCIAS MÉDICAS [UNESCO]ArthroplastySurgeryTemporomandibular jointOrofacial Pain-TMJDSkullstomatognathic diseasesmedicine.anatomical_structureTreatment OutcomeOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgeryFemalebusinessFollow-Up Studies
researchProduct

Mechanical step variability during treadmill running.

1995

The present study was designed to study intra-individual step variability measured both on vertical displacement of the body (delta Z) and on step time (delta t) parameters by means of a kinematic arm and during treadmill running. A group of 17 subjects ran successively at 60%, 80%, 100% and 140% of their maximal aerobic velocity (Vamax). The total number of steps analysed was 6116. The absolute delta Z step variability (sigma delta Z) ranged between 5 mm and 21 mm while the absolute delta t variability (sigma delta t) ranged between 6 ms and 40 ms. Step variabilities were due to step asymmetry (from 38.5% to 48.5% of the step variability) and to stride variability. For submaximal velocitie…

AdultMalemedicine.medical_specialtyFuture studiesPhysiologyPhysical ExertionEnergetic costSTRIDEKinematicsRunningTreadmill runningPhysiology (medical)StatisticsmedicineHumansOrthopedics and Sports MedicineVertical displacementMathematicsMean valuePublic Health Environmental and Occupational HealthGeneral MedicineOxygenData Interpretation StatisticalEnergy costPhysical therapyExercise TestEnergy MetabolismEuropean journal of applied physiology and occupational physiology
researchProduct

Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa.

2013

Globotriaosylceramide concentrations were assessed as potential predictors of change from baseline after 12 months by estimated glomerular filtration rate and left-ventricular mass index using pooled data from three randomized, placebo-controlled agalsidase alfa trials and open-label extensions of patients with Fabry disease.Males (aged 18 years or older) with Fabry disease received agalsidase alfa (0.2 mg/kg every other week for 12 months). A backward-elimination approach evaluated potential predictors (baseline estimated glomerular filtration rate and left-ventricular mass index; age at first dose; baseline and change from baseline at 12 months of globotriaosylceramide (urine, plasma); ur…

AdultMalemedicine.medical_specialtyHeart VentriclesUrologyGlobotriaosylceramideRenal functionUrinechemistry.chemical_compoundYoung Adultstomatognathic systemDouble-Blind MethodMedicineHumansRenal Insufficiency Chronicskin and connective tissue diseasesGenetics (clinical)Alpha-galactosidasebiologybusiness.industryTrihexosylceramidesvirus diseasesEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseasedigestive system diseasesRecombinant ProteinsIsoenzymesTreatment Outcomechemistryalpha-Galactosidasebiology.proteinDisease ProgressionBiomarker (medicine)Fabry Diseasesense organsbusinessBiomarkersKidney diseaseGlomerular Filtration RateGenetics in medicine : official journal of the American College of Medical Genetics
researchProduct

Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.

2007

Aims Anderson–Fabry disease (AFD) is an uncommon X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A. The Fabry Outcome Survey is a European database designed to monitor the long-term efficacy and safety of enzyme replacement therapy (ERT) with agalsidase alfa. The aim of this study was to determine the prevalence and characteristics of cardiac disease in AFD patients. Methods and results Clinical and laboratory data were available in 714 patients from 11 countries (mean age 35 ± 17 years, 369 women, 336 treated). The prevalence of angina was 23 vs. 22%; palpitations and arrhythmias 27 vs. 26%; exertional dyspnoea 23 vs. 23%; and syncope 2 vs. 4%, in wom…

AdultMalemedicine.medical_specialtyHeart diseaseHeart DiseasesCardiomyopathyLeft ventricular hypertrophySyncopeAnginaRisk FactorsInternal medicinemedicinePalpitationsPrevalenceHumansVascular diseasebusiness.industryEnzyme replacement therapyMiddle Agedmedicine.diseaseFabry diseaseRecombinant ProteinsSurgeryEuropeIsoenzymesDyspneaTreatment OutcomeEchocardiographyalpha-GalactosidaseFabry DiseaseFemaleHypertrophy Left Ventricularmedicine.symptomCardiology and Cardiovascular MedicinebusinessGlomerular Filtration RateEuropean heart journal
researchProduct

Five times sit-to-stand test in subjects with total knee replacement: Reliability and relationship with functional mobility tests

2017

The objective was to determine the inter-observer and test/retest reliability of the "Five-repetition sit-to-stand" (5STS) test in patients with total knee replacement (TKR). To explore correlation between 5STS and two mobility tests. A reliability study was conducted among 24 (mean age 72.13, S.D. 10.67; 50% were women) outpatients with TKR. They were recruited from a traumatology unit of a public hospital via convenience sampling. A physiotherapist and trauma physician assessed each patient at the same time. The same physiotherapist realized a 5STS second measurement 45-60min after the first one. Reliability was assessed with intraclass correlation coefficients (ICCs) and Bland-Altman plo…

AdultMalemedicine.medical_specialtyHeteroscedasticityIntraclass correlationPosturePopulationBiophysicsTraumatologyCorrelation03 medical and health sciencessymbols.namesake0302 clinical medicineActivities of Daily LivingmedicineHumansOrthopedics and Sports MedicineArthroplasty Replacement KneeeducationGaitReliability (statistics)AgedAged 80 and overObserver Variationeducation.field_of_studybusiness.industryRehabilitationReproducibility of ResultsRecovery of Function030229 sport sciencesMiddle AgedConfidence intervalPearson product-moment correlation coefficientsymbolsPhysical therapyFemalebusiness030217 neurology & neurosurgeryGait & Posture
researchProduct

Gender-, age- and time-dependent dosing of growth hormone in adults - real-world data from a decade of clinical practice in Germany.

2017

We evaluated treatment patterns and gender-dependent dosing of growth hormone (GH) substitution in adults with GH deficiency (AGHD). Data on GH dose were collected (2003-2013) from 509 GH-treated patients (mean age: 48.9 years; 47% female) enroled in the observational German NordiWin study (NCT01543880). The impact of gender, age, treatment duration and calendar year on GH treatment patterns was evaluated by multiple regression analysis. Mean (SD) baseline GH dose (mg/day) was similar between females (0.25 [0.19] and males (0.24 [0.15]), but increased with treatment duration (at year 10, 0.55 [0.48] and 0.31 [0.09] in females and males, respectively), reflecting patient dose titration. GH d…

AdultMalemedicine.medical_specialtyHormone Replacement TherapyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPhysiology030209 endocrinology & metabolismGrowth hormoneGrowth hormone deficiency03 medical and health sciencesInsulin-like growth factor0302 clinical medicineEndocrinologySex FactorsInternal medicineGermanymedicineHumansDosingDwarfism PituitaryAgedDose-Response Relationship Drugbusiness.industryHuman Growth HormoneAge FactorsObstetrics and GynecologyMiddle Agedmedicine.diseaseClinical PracticeEndocrinologyTreatment OutcomeTransgender hormone therapy030220 oncology & carcinogenesisGh treatmentFemalebusinessReal world dataGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Development and application to clinical practice of a validated HPLC method for the analysis of β-glucocerebrosidase in Gaucher disease.

2014

The main objective of our study is to develop a simple, fast and reliable method for measuring ß-glucocerebrosidase activity in Gaucher patients leukocytes in clinical practice. This measurement may be a useful marker to drive dose selection and early clinical decision making of enzyme replacement therapy. We measure the enzyme activity by high-performance liquid chromatography with ultraviolet detection and 4-nitrophenyl-ß-d-glucopyranoside as substrate. A cohort of eight Gaucher patients treated with enzyme replacement therapy and ten healthy controls were tested; median enzyme activity values was 20.57mU/ml (interquartile range 19.92-21.53mU/ml) in patients and mean was 24.73mU/ml (24.12…

AdultMalemedicine.medical_specialtyImigluceraseAdolescentUltraviolet RaysClinical BiochemistryUrologyPharmaceutical ScienceAnalytical ChemistryInterquartile rangeDrug DiscoverymedicineLeukocytesHumansDosingProspective StudiesProspective cohort studyChildSpectroscopyEnzyme activity Gaucher disease HPLC Imiglucerase ß-GlucocerebrosidaseChromatography High Pressure LiquidGaucher DiseasebiologyChemistryEnzyme replacement therapyMiddle AgedEnzyme assayGlucosylceramidaseBiochemistrybiology.proteinGlucosylceramidaseFemaleGlucocerebrosidasemedicine.drugJournal of pharmaceutical and biomedical analysis
researchProduct

Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.

2015

Purpose: To evaluate whole-body magnetic resonance imaging (WB-MRI) for the assessment of bone marrow infiltration in patients with confirmed Gaucher disease type 1 under long-term enzyme replacement therapy (ERT). Materials and Methods: This retrospective data analysis included 38 patients in two subgroups. Group A: 10 females, 9 males, 15 – 29 years, mean age 22 years and Group B: 11 females, 8 males, 29 – 77 years, mean age 49 years, all treated with alglucerase or imiglucerase for at least 12.5 years. Whole-body MRI was carried out in all patients using a standard MRI protocol. Two radiologists assessed all MR images retrospectively with the use of three different MRI score systems: The…

AdultMalemedicine.medical_specialtyImigluceraseAdolescentYoung AdultAlgluceraseBone MarrowmedicineHumansRadiology Nuclear Medicine and imagingWhole Body ImagingYoung adultAgedRetrospective StudiesGaucher Diseasemedicine.diagnostic_testbusiness.industryMagnetic resonance imagingRetrospective cohort studyEnzyme replacement therapyMiddle AgedMagnetic Resonance ImagingSurgeryVertebramedicine.anatomical_structureBody BurdenFemaleRadiologyBone marrowbusinessmedicine.drugRoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin
researchProduct

CD3+ lymphocytosis in the peri-implant membrane of 222 loosened joint endoprostheses depends on the tribological pairing.

2017

Background and purpose — The most frequent cause of arthroplasty failure is aseptic loosening—often induced by particles. Abrasion material triggers inflammatory reactions with lymphocytic infiltration and the formation of synovial-like interface membranes (SLIM) in the bone–implant interface. We analyzed CD3 quantities in SLIM depending on articulating materials and possible influences of proven material allergies on CD3 quantities. Patients and methods — 222 SLIM probes were obtained from revision surgeries of loosened hip and knee arthroplasties. SLIM cases were categorized according to the SLIM-consensus classification and to the particle algorithm. The CD3 quantities were analyzed immu…

AdultMalemedicine.medical_specialtyLymphocytosisCD3 Complexmedicine.medical_treatmentArthroplasty Replacement HipT-LymphocytesAbrasion (medical)Lymphocytosis03 medical and health sciences0302 clinical medicinemedicineHumansOrthopedics and Sports MedicineLymphocyte CountArthroplasty Replacement KneeAgedOrthopedic surgeryAged 80 and overHipbusiness.industrySynovial MembraneGeneral MedicineMiddle Aged030224 pathologymedicine.diseaseArthroplastyImmunohistochemistrySurgeryProsthesis Failure030220 oncology & carcinogenesisSurgeryFemaleAseptic processingImplantHip Prosthesismedicine.symptombusinessRD701-811Acta orthopaedica
researchProduct